Director Mauro Gregorio filed a Form 4 with the SEC on September 3, 2026, disclosing the vesting of 936 restricted stock units and an acquisition of 936 shares of Graham Corporation common stock on September 2, 2026.
Mark W. Johnson, Chief Legal Officer and Corporate Secretary of Mativ Holdings, Inc., filed a Form 4 on September 3, 2026, reporting the vesting and cash settlement of 6,444 restricted stock units on September 1, 2026.
Sarah Krepp, Chief Human Resource Officer of Liquidia Corp (NASDAQ:LQDA), filed a Form 4 on September 3, 2026, disclosing a sale of 274 shares of common stock on September 1, 2026, executed under a pre-established Rule 10b5-1 trading plan.
A Form 4 filed with the SEC on September 3, 2026 discloses that Ashish Arora, Chief Executive Officer and Director of Cricut, Inc. (NASDAQ:CRCT), sold a combined 120,000 shares of Class A Common Stock on September 2 and September 3, 2026, under a pre-established …
Samantha L. Sloan, Executive Vice President of Corporate Affairs at First Solar, Inc. (NASDAQ:FSLR), filed a Form 4 on September 3, 2026, disclosing transactions in the company's common stock on September 1, 2026, related to the vesting of restricted stock units.
A Form 4 filed on September 3, 2026 discloses that Jennifer Newstead, Senior Vice President, General Counsel and Government Affairs at Apple Inc. (NASDAQ:AAPL), sold 1,439 shares of Apple common stock on September 1, 2026.
A statement of changes in beneficial ownership filed on September 3, 2026 reports that John L. Thornton, a director of Ford Motor Co, acquired Ford Stock Units on September 1, 2026 through the company's Deferred Compensation Plan for Non-Employee Directors.
A Form 4 filed on September 3, 2026 discloses that James E. Davis, CEO and President of Quest Diagnostics Inc (NYSE:DGX), sold 10,000 shares of common stock on September 1, 2026 pursuant to a pre-established Rule 10b5-1 sales plan.
A Form 4 filed on September 3, 2026 discloses that Michael K. Burke, a director of Casella Waste Systems Inc (NASDAQ:CWST), sold 1,100 shares of Class A Common Stock on September 3, 2026.
Serge Saxonov, Chief Executive Officer and Director of 10x Genomics, Inc. (NASDAQ:TXG), filed a Form 4 on September 3, 2026, reporting a change in beneficial ownership of Class A Common Stock with a transaction dated September 1, 2026.